What is the official ID of this bill?

The official print number for this legislation is HR 2829.

When did the legislative process begin?

The process officially started on 2021-04-22.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/117/bills/hr2829/BILLS-117hr2829ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

Who is the primary sponsor?

The primary sponsor is Rep. Welch, Peter [D-VT-At Large].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Analysis and Potential Impact of HR 2829

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

End Drug Price Gouging: Lower Medication Costs for All

Q: What are the main provisions?

Key points include: Establishes maximum prescription drug prices based on international rates, potentially lowering costs for patients. Lower drug prices will apply to federal health programs (e.g., Medicare, Medicaid) and all individuals, including the uninsured. Drug manufacturers selling above the set price will face financial penalties, with funds supporting new drug research.

This bill aims to lower prescription drug prices by setting maximum prices based on international rates. This means medications in federal programs, and for uninsured individuals, could become more affordable. Manufacturers who do not comply will face penalties, with collected funds directed towards new drug research.

Key points

Establishes maximum prescription drug prices based on international rates, potentially lowering costs for patients.

Lower drug prices will apply to federal health programs (e.g., Medicare, Medicaid) and all individuals, including the uninsured.

Drug manufacturers selling above the set price will face financial penalties, with funds supporting new drug research.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

End Price Gouging for Medications Act

Print number: HR 2829

Sponsor: Rep. Welch, Peter [D-VT-At Large]

Process start date: 2021-04-22

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

End Drug Price Gouging: Lower Medication Costs for All

Key Questions about End Drug Price Gouging: Lower Medication Costs for All